Filing Details

Accession Number:
0001562180-19-005059
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-02 16:21:19
Reporting Period:
2019-10-01
Accepted Time:
2019-10-02 16:21:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1685071 Dova Pharmaceuticals Inc. DOVA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627642 David Zaccardelli C/O Dova Pharmaceuticals, Inc.
240 Leigh Farm Road, Suite 245
Durham NC 27707
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-10-01 5,275 $27.90 76,647 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.84 to $28.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.